Swixx BioPharma AG, a global commercial platform dedicated to unlocking access to innovative medicines worldwide, announces its strategic expansion into Latin America with the signature of an agreement to acquire 100% of the equity of Pharma Consulting Group S.A. the holding company of Laboratorios Biopas SA.
BioCryst Pharmaceuticals is collaborating with Swixx Biopharma for Orladeyo (berotralstat) commercialisation in Central and Eastern Europe (CEE).